Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1158405411 | 11584054 | 11 | F | 20111012 | 20160708 | 20151001 | 20160722 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2015VAL000490 | VALIDUS | 0.00 | Y | 0.00000 | 20160722 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1158405411 | 11584054 | 1 | PS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 50 MG, BID | Y | 17963 | 50 | MG | |||||||
| 1158405411 | 11584054 | 2 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 25 MG, BID | Y | 17963 | 25 | MG | |||||||
| 1158405411 | 11584054 | 3 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 25 MG, QD | Y | 17963 | 25 | MG | |||||||
| 1158405411 | 11584054 | 4 | SS | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Subcutaneous | UNK UG, ONCE/SINGLE | 0 | ||||||||||
| 1158405411 | 11584054 | 5 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, BIW (EVERY 2 WEEKS) | U | 0 | 40 | MG | |||||||
| 1158405411 | 11584054 | 6 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 20 MG, BIW EVERY 2 WEEKS | U | 0 | 20 | MG | |||||||
| 1158405411 | 11584054 | 7 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, BIW EVERY 2 WEEKS | U | S0098C | 0 | 30 | MG | ||||||
| 1158405411 | 11584054 | 8 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 30 MG, UNK | U | 0 | 30 | MG | |||||||
| 1158405411 | 11584054 | 9 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 40 MG, BIW (EVERY 2 WEEKS) | U | 0 | 40 | MG | |||||||
| 1158405411 | 11584054 | 10 | SS | SANDOSTATIN LAR DEPOT | OCTREOTIDE ACETATE | 1 | Intramuscular | 60 MG, BIW (EVERY 2 WEEKS) | U | 0 | 60 | MG | |||||||
| 1158405411 | 11584054 | 11 | C | LANTUS | INSULIN GLARGINE | 1 | Subcutaneous | BEDTIME | 0 | ||||||||||
| 1158405411 | 11584054 | 12 | C | NOVORAPID | INSULIN ASPART | 1 | Subcutaneous | 4 TO 5 TIMES A DAY | U | 0 | |||||||||
| 1158405411 | 11584054 | 13 | C | RAMIPRIL. | RAMIPRIL | 1 | UNK | U | 0 | ||||||||||
| 1158405411 | 11584054 | 14 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | UNK | U | 0 | ||||||||||
| 1158405411 | 11584054 | 15 | C | ASAPHEN | ASPIRIN | 1 | UNK | U | 0 | ||||||||||
| 1158405411 | 11584054 | 16 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 1158405411 | 11584054 | 17 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | UNK | U | 0 | ||||||||||
| 1158405411 | 11584054 | 18 | C | RABEPRAZOLE | RABEPRAZOLE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 1158405411 | 11584054 | 1 | Product used for unknown indication |
| 1158405411 | 11584054 | 4 | Carcinoid syndrome |
| 1158405411 | 11584054 | 5 | Carcinoid syndrome |
| 1158405411 | 11584054 | 11 | Product used for unknown indication |
| 1158405411 | 11584054 | 12 | Product used for unknown indication |
| 1158405411 | 11584054 | 13 | Product used for unknown indication |
| 1158405411 | 11584054 | 14 | Product used for unknown indication |
| 1158405411 | 11584054 | 15 | Product used for unknown indication |
| 1158405411 | 11584054 | 16 | Product used for unknown indication |
| 1158405411 | 11584054 | 17 | Product used for unknown indication |
| 1158405411 | 11584054 | 18 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 1158405411 | 11584054 | LT |
| 1158405411 | 11584054 | HO |
| 1158405411 | 11584054 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 1158405411 | 11584054 | 5-hydroxyindolacetic acid in urine increased | |
| 1158405411 | 11584054 | Abdominal discomfort | |
| 1158405411 | 11584054 | Abdominal distension | |
| 1158405411 | 11584054 | Abdominal mass | |
| 1158405411 | 11584054 | Abdominal pain | |
| 1158405411 | 11584054 | Abdominal pain upper | |
| 1158405411 | 11584054 | Arthralgia | |
| 1158405411 | 11584054 | Asthenia | |
| 1158405411 | 11584054 | Blood chromogranin A increased | |
| 1158405411 | 11584054 | Blood glucose decreased | |
| 1158405411 | 11584054 | Blood glucose fluctuation | |
| 1158405411 | 11584054 | Blood pressure diastolic decreased | |
| 1158405411 | 11584054 | Blood pressure systolic increased | |
| 1158405411 | 11584054 | Diabetes mellitus | |
| 1158405411 | 11584054 | Diarrhoea | |
| 1158405411 | 11584054 | Discomfort | |
| 1158405411 | 11584054 | Disorientation | |
| 1158405411 | 11584054 | Dyspnoea | |
| 1158405411 | 11584054 | Fatigue | |
| 1158405411 | 11584054 | Feeling abnormal | |
| 1158405411 | 11584054 | Flushing | |
| 1158405411 | 11584054 | Frequent bowel movements | |
| 1158405411 | 11584054 | Gait disturbance | |
| 1158405411 | 11584054 | Gastrointestinal hypomotility | |
| 1158405411 | 11584054 | Heart rate decreased | |
| 1158405411 | 11584054 | Hyperhidrosis | |
| 1158405411 | 11584054 | Hypotension | |
| 1158405411 | 11584054 | Inappropriate schedule of drug administration | |
| 1158405411 | 11584054 | Incorrect dose administered | |
| 1158405411 | 11584054 | Injection site bruising | |
| 1158405411 | 11584054 | Injection site discomfort | |
| 1158405411 | 11584054 | Injection site mass | |
| 1158405411 | 11584054 | Injection site pain | |
| 1158405411 | 11584054 | Injection site scar | |
| 1158405411 | 11584054 | Macular degeneration | |
| 1158405411 | 11584054 | Malignant neoplasm progression | |
| 1158405411 | 11584054 | Nausea | |
| 1158405411 | 11584054 | Needle issue | |
| 1158405411 | 11584054 | Oncologic complication | |
| 1158405411 | 11584054 | Sleep disorder | |
| 1158405411 | 11584054 | Syncope | |
| 1158405411 | 11584054 | Therapeutic response decreased | |
| 1158405411 | 11584054 | Underdose | |
| 1158405411 | 11584054 | Visual acuity reduced | |
| 1158405411 | 11584054 | Visual impairment |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 1158405411 | 11584054 | 4 | 20110927 | 20110927 | 0 | |
| 1158405411 | 11584054 | 5 | 20111012 | 0 | ||
| 1158405411 | 11584054 | 7 | 20110927 | 0 | ||
| 1158405411 | 11584054 | 8 | 20140606 | 0 |